SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 112,500 shares of its common stock to eight new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
WHITE PLAINS, N.Y., April 21, 2025 (GLOBE NEWSWIRE) -- NorthEast Community Bancorp, Inc. (Nasdaq: NECB)…
OWNx, a pioneer in precious metals investment since 2008, today announced the launch of OWNx…
Raleigh, NC, April 21, 2025 (GLOBE NEWSWIRE) -- VitalSource announced today it has acquired RedShelf,…
LUXEMBOURG, April 21, 2025 (GLOBE NEWSWIRE) -- In response to a number of media speculations…
Toronto, April 21, 2025 (GLOBE NEWSWIRE) -- Ceylon Graphite Corp. (TSXV: CYL) (“Ceylon” or the…
Engineering firm’s longevity built on employee strength and innovationOLATHE, Kan., April 21, 2025 (GLOBE NEWSWIRE)…
This website uses cookies.